stockrowPraxis Precision Medicines, Inc.
PRAX Healthcare Biotechnology
Praxis Precision Medicines, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $8.6 million, up 249.5% from fiscal 2023.
- Revenue
- +1,349.1%
- EPS
- +13.3%
- Free cash flow
- −43.5%
Quarter to June 2026, against a year earlier
Follow PRAX
Alert me
Praxis Precision Medicines, Inc. (PRAX) Net income
Praxis Precision Medicines, Inc.'s net income for fiscal 2025 was −$303.3M, compared with −$182.8M in fiscal 2024. Over the twelve months to 30 June 2026 it was −$339.1M. Over the past ten years it has ranged from −$303.3M (fiscal 2025) to $0.00 (fiscal 2017) — the current reading is the lowest in ten years. Praxis Precision Medicines, Inc. ranks 565th of 605 Biotechnology companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | −$303.3M | — |
| FY2024 | −$182.8M | — |
| FY2023 | −$123.3M | — |
| FY2022 | −$214.0M | — |
| FY2021 | −$167.1M | — |
| FY2020 | −$61.8M | — |
| FY2019 | −$35.5M | — |
| FY2018 | −$26.5M | — |
| FY2017 | $0.00 | — |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Jun 2026 | −$83.7M | — |
| Mar 2026 | −$92.6M | — |
| Dec 2025 | −$88.9M | — |
| Sep 2025 | −$73.9M | — |
| 25 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| KRYS Krystal Biotech, Inc. compare | $225.2M |
| CORT Corcept Therapeutics Incorporated compare | $162.3M |
| AXSM Axsome Therapeutics, Inc. compare | −$157.3M |
| RYTM Rhythm Pharmaceuticals, Inc. compare | −$193.8M |
| SYRE Spyre Therapeutics, Inc. compare | −$263.9M |
| ARWR Arrowhead Pharmaceuticals, Inc. compare | −$272.1M |
| PRAX Praxis Precision Medicines, Inc. | −$339.1M |
| ABVX Abivax SA Sponsored ADR compare | −$458.7M |
| CYTK Cytokinetics, Incorporated compare | −$777.9M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item